May 10, 2017
BEVERLY, MA--(Marketwired - May 10, 2017) - BioVie Inc. (OTCQB: BIVI), a clinical-stage company focused on the discovery, development, and commercialization of innovative drug therapies for liver disease, today welcomed Dr. Hari Kumar, a highly accomplished biopharmaceutical industry executive, to ...
Apr 25, 2017
BEVERLY, MA--(Marketwired - April 25, 2017) - BioVie Inc. (OTCQB: BIVI), a clinical-stage company focused on the discovery, development, and commercialization of innovative drug therapies for liver disease, today announced the signing of a Cooperative Research and Development Agreement (CRADA) to c...
Apr 3, 2017
BioVie's Core Patent Covering BIV201 as Treatment for Ascites Allowed by US Patent Office